Brief: Anika Therapeutics Q1 revenue USD 37.924 million

Anika Therapeutics

09/05/2023 21:09

May 9 (Reuters) - Anika Therapeutics Q1 revenue USD 37.924 million.
* Q1 income from operations USD -12.553 million
* Q1 pretax profit USD -12.014 million
* Q1 gross profit USD 22.843 million
* Q1 net income USD -10.35 million